Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Influenza Hemagglutinin (HA) Peptide: Precision Epitope T...

    2026-03-20

    Influenza Hemagglutinin (HA) Peptide: Precision Epitope Tag for Protein Purification and Detection

    Principle and Setup: Harnessing the Power of the HA Tag Peptide

    The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a nine-amino acid synthetic peptide derived from the human influenza virus hemagglutinin protein. As a high-purity (>98%) molecular biology reagent, it functions as a robust epitope tag for protein detection and purification, revolutionizing workflows in biochemistry and cell biology. Its competitive binding to anti-HA antibodies enables selective elution of HA-tagged fusion proteins from immunoprecipitation matrices, such as Anti-HA Magnetic Beads or conventional antibody-bound supports.

    Key attributes include remarkable solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), ensuring compatibility with diverse biochemical protocols. This DMSO soluble peptide is validated by HPLC and mass spectrometry, minimizing background and maximizing reproducibility. The HA tag peptide's sequence (YPYDVPDYA) is widely adopted in molecular cloning vectors, providing a universal platform for protein tagging and detection across expression systems.

    As a protein purification tag and an epitope tag for protein detection, the HA peptide is integral to workflows ranging from immunoprecipitation with Anti-HA antibodies to advanced protein-protein interaction studies. Its role was highlighted in a recent Nature Chemical Biology article on IDH1 autopalmitoylation (Hu et al., 2025), where HA-tagged IDH1 constructs enabled precise mapping of post-translational modifications and interaction partners.

    Step-by-Step Workflow: Enhancing Immunoprecipitation and Purification Protocols

    1. Construct Design and Expression

    Begin by fusing the HA tag DNA sequence (encoding YPYDVPDYA) to the C- or N-terminus of your protein of interest using a suitable expression vector. The compact nature of the hemagglutinin tag minimizes steric hindrance, preserving native protein function and localization. Ensure proper reading frame and verify the ha tag nucleotide sequence to avoid truncations or frame shifts.

    2. Cell Lysis and Preparation

    Harvest transfected or transduced cells expressing the HA-tagged protein. Lyse cells using a buffer compatible with downstream immunoprecipitation (e.g., Tris or HEPES-based lysis buffer supplemented with protease inhibitors). Clarify lysates by centrifugation.

    3. Immunoprecipitation Assay

    Add clarified lysate to Anti-HA Magnetic Beads or immobilized anti-HA antibody matrices. Incubate at 4°C with gentle agitation to allow the antibody-antigen interaction between the HA tag and anti-HA antibody. Wash beads stringently to eliminate non-specific binders, ensuring high-purity enrichment of the HA fusion protein.

    4. Competitive Elution with HA Peptide

    For gentle elution of the bound HA-tagged protein, incubate the beads with a freshly prepared solution of Influenza Hemagglutinin (HA) Peptide (typically 0.5–5 mg/mL, depending on bead capacity and protein abundance). The peptide competitively displaces the HA fusion protein by binding the anti-HA antibody, enabling specific recovery under non-denaturing conditions—critical for downstream assays such as mass spectrometry or activity measurements.

    5. Downstream Analysis

    Analyze the eluate by SDS-PAGE, Western blotting (using anti-HA or target-specific antibodies), enzymatic assays, or proteomics. The high purity peptide ensures minimal contamination, yielding clean bands and accurate quantification.

    Protocol Innovation

    Recent comparative studies, such as those synthesized in "Influenza Hemagglutinin (HA) Peptide: Optimizing HA Tag Purification", demonstrate that inclusion of the synthetic HA peptide during elution can increase recovery yields by up to 30% over low-pH or chaotropic elution methods—while preserving protein activity and complex integrity.

    Advanced Applications and Comparative Advantages

    Precision Mapping of Protein Interactions

    The HA tag is a gold standard in protein-protein interaction studies, enabling both single-step and tandem affinity purification. In the context of the IDH1-R132H autopalmitoylation study (Hu et al., 2025), HA-tagged IDH1 constructs were subjected to immunoprecipitation followed by streptavidin blotting to dissect post-translational modification–dependent binding partners. The competitive elution strategy using the HA tag peptide preserved labile associations and post-translational marks—crucial for mapping dynamic signaling events.

    Ubiquitination and Exosome Pathway Dissection

    As detailed in "Influenza Hemagglutinin (HA) Peptide: Precision Tag for Ubiquitination Studies", the HA peptide serves as a reliable immunoprecipitation tag peptide in dissecting ubiquitin-mediated protein turnover and ESCRT-independent exosome pathways. Its specificity allows discrimination between closely related protein isoforms, supporting high-sensitivity detection in complex mixtures.

    Comparative Advantages

    • Minimal Cross-Reactivity: The influenza hemagglutinin epitope is rarely found in mammalian proteomes, minimizing background in immunoassays.
    • Gentle, Non-Denaturing Elution: Competitive HA peptide elution preserves protein conformation and binding partners.
    • High Solubility and Stability: The HA tag peptide remains stable at -20°C (desiccated), and its solutions can be freshly prepared in water, DMSO, or ethanol for immediate use.
    • Multipurpose Utility: Seamless integration into workflows for Western blot, immunofluorescence, immunoprecipitation assay, and proteomics.

    Further, as "Influenza Hemagglutinin (HA) Peptide: Precision Tag for Advanced Molecular Biology" complements, the HA tag's robust solubility and purity facilitate reproducibility in high-throughput and single-cell workflows, extending its utility to emerging domains such as exosome research and chromatin profiling.

    Troubleshooting and Optimization Tips

    • Low Yield in HA Peptide Elution: Ensure the anti-HA antibody is not saturated and that the peptide concentration is sufficient (up to 5 mg/mL for high-capacity beads). Extend incubation to 30–60 minutes at 4°C for maximal recovery.
    • Protein Degradation: Include protease inhibitors during lysis and all wash steps. Work on ice wherever possible.
    • Non-Specific Binding: Increase stringency of wash buffers (e.g., add 0.1–0.3% Triton X-100 or NP-40). Pre-clear lysates with control beads if background persists.
    • Peptide Storage: Store lyophilized peptide at -20°C, desiccated. Avoid repeated freeze-thaw cycles and prepare fresh working solutions as needed to maintain high activity.
    • Solubility Issues: Dissolve the peptide first in DMSO or ethanol before dilution into aqueous buffers for optimal solubility. The peptide is DMSO soluble at ≥55.1 mg/mL and remains stable in solution for short periods.
    • Epitope Accessibility: Confirm the HA tag is accessible in your protein's native structure; C- or N-terminal fusions typically yield the best results. If detection is weak, test both termini or introduce flexible linkers.

    For additional troubleshooting scenarios and practical tips, "Influenza Hemagglutinin (HA) Peptide: Reliable Tagging for Cell-Based Assays" provides scenario-driven Q&As, extending the guidance provided here for both novice and advanced users.

    Future Outlook: Scaling Innovation in Protein Science with the HA Tag

    The Influenza Hemagglutinin (HA) Peptide continues to shape next-generation molecular biology, from high-throughput interactomics to synthetic biology platform development. As highlighted by APExBIO, ongoing improvements in peptide purity and antibody affinity are pushing the boundaries of sensitivity and reproducibility in immunoassay reagent design.

    Emerging workflows, such as those integrating proximity labeling or single-cell proteomics, leverage the HA tag sequence for rapid, multiplexed protein detection. The HA peptide's compatibility with gentle elution protocols ensures that labile protein complexes and transient modifications—such as those characterized in the recent study of IDH1-R132H autopalmitoylation (Hu et al., 2025)—can be captured and analyzed with high fidelity.

    As the field advances, expect further protocol innovations and custom HA tag DNA sequence vectors optimized for emerging host systems. The versatility of the HA tag, combined with the reliability of APExBIO's supply chain, positions the Influenza Hemagglutinin (HA) Peptide as an essential tool in both routine and cutting-edge protein science.